Role of the renin-angiotensin system in the promotion of atrial fibrillation

Acta Cardiologica

Volumn 64, Issue 6, 2009, Pages 843-

  Ramaraj, Radhakrishnan ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

HEART ATRIUM FIBRILLATION; LETTER; MEDICAL RESEARCH; RECURRENT DISEASE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINUS RHYTHM;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATRIAL FIBRILLATION; CATHETER ABLATION; HUMANS; RECURRENCE; RENIN-ANGIOTENSIN SYSTEM;

EID: 74749098241     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.64.6.2044757     Document Type: Letter

References (5)

1. Zheng B, Kang J, Tian Y, Tang R, Long D, Yu R, He H, Zhang M, Shi L, Tao H, Liu X, Dong J, Ma C. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation. Acta Cardiol 2009; 64: 335-40.
2. Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 2000; 101: 2612-7.
3. Ehrlich JR, Hohnloser SH, Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J 2006; 27: 512-8.
4. Kumagai K, Nakashima H, Urata H, Gondo N, Arakawa K, Saku K. Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Coll Cardiol 2003; 41: 2197-204.
5. Kawamura M, Ito H, Onuki T, Miyoshi F, Minoura Y, Asano T, Tanno K, Kobayashi Y. Combination therapy of renin angiotensin system inhibitors and bepridil is useful for maintaining sinus rhythm in patients with atrial fibrillation. J Cardiol 2007; 50: 343-50.